Founded with the mission to revolutionize drug delivery systems, Isis Biopolymer Inc. focuses on developing advanced transdermal patches. These patches are designed to deliver medications into the bloodstream non-invasively, ensuring a controlled and repeatable process. Their products cater to various medical needs, including anti-wrinkle and anti-aging treatments, positioning themselves in the healthcare and cosmetic markets.

Notable for its innovative approach, Isis Biopolymer has attracted attention from key industry investors and experts in medical device development. The company has achieved significant milestones in creating effective non-invasive drug delivery solutions, impacting patient care by offering an alternative to traditional methods. Their advancements contribute to the broader field of medical technology, enhancing both therapeutic outcomes and patient comfort.